Eversept Partners LP Makes New Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Eversept Partners LP bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 139,656 shares of the medical instruments supplier's stock, valued at approximately $2,651,000. Eversept Partners LP owned approximately 0.07% of DENTSPLY SIRONA at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Pacer Advisors Inc. lifted its holdings in DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. Nuance Investments LLC lifted its stake in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after buying an additional 2,708,097 shares in the last quarter. Norges Bank acquired a new position in DENTSPLY SIRONA during the fourth quarter worth about $45,730,000. Cooke & Bieler LP grew its stake in DENTSPLY SIRONA by 24.3% during the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after acquiring an additional 1,794,391 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on XRAY. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Barrington Research lowered their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their target price for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Mizuho decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target for the company. in a research report on Tuesday, April 15th. Thirteen research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $22.58.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier acquired 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Up 0.3 %

Shares of NASDAQ:XRAY traded up $0.04 on Friday, hitting $13.75. 2,078,513 shares of the company's stock were exchanged, compared to its average volume of 2,965,814. The company has a market capitalization of $2.74 billion, a PE ratio of -6.64, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $31.00. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm's 50-day moving average is $15.09 and its 200 day moving average is $18.33.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.65%. DENTSPLY SIRONA's payout ratio is -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.